Does CILTACABTAGENE AUTOLEUCEL Cause Parkinsonism? 209 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 209 reports of Parkinsonism have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 5.5% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
209
Reports of Parkinsonism with CILTACABTAGENE AUTOLEUCEL
5.5%
of all CILTACABTAGENE AUTOLEUCEL reports
39
Deaths
59
Hospitalizations
How Dangerous Is Parkinsonism From CILTACABTAGENE AUTOLEUCEL?
Of the 209 reports, 39 (18.7%) resulted in death, 59 (28.2%) required hospitalization, and 3 (1.4%) were considered life-threatening.
Is Parkinsonism Listed in the Official Label?
Yes, Parkinsonism is listed as a known adverse reaction in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
Cranial nerve paralysis (115)
What Other Drugs Cause Parkinsonism?
ARIPIPRAZOLE (912)
OLANZAPINE (856)
RISPERIDONE (797)
QUETIAPINE (778)
VALBENAZINE (549)
HALOPERIDOL (352)
CLOZAPINE (347)
SERTRALINE (297)
PALIPERIDONE (272)
LITHIUM (263)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Parkinsonism Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE